Publication | Closed Access

Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial

UrologyOncologyOptimal SequencingCrossover TrialGenitourinary CancerMedicinePharmacotherapyCancer TreatmentPhase 2Prostatic DiseasePharmacology